Retatrutide trial shows 30% body weight loss, rivalling bariatric surgery results
HQ Team June 17, 2026: Retatrutide, an experimental “triple-agonist” weight-loss drug developed by Eli Lilly, helped patients lose nearly a third of their
Drugs
Health
Climate
Heatwaves linked to 26,500 ozone deaths in India in 2024: IIT study
HQ Team June 16, 2026: Heatwaves across India may have intensified ground-level ozone pollution linked to more than 26,500 deaths in 2024, according
Drugs
Pharma
FDA expands approval of kidney cancer drug to earlier-stage patients
HQ Team June 16, 2026: The US Food and Drug Administration (FDA) has expanded approval of belzutifan, a first-in-class kidney cancer drug, to
Drugs
Health
Experimental Fentanyl vaccine prevents drug and variants from reaching brain
HQ Team June 15, 2026: Researchers at Scripps Research in California have developed an experimental vaccine that reduced fentanyl levels in the brains
Health
GLP- 1 Ozempic, Wegovy drug users move less, not more, new study finds
HQ Team June 15, 2026: Adults with obesity who started GLP-1 weight-loss drugs like Ozempic and Wegovy at a US hospital in Illinois
Health
Why humans prefer to turn counterclockwise: New Research explains the mystery
HQ Team June 11, 2026: Researchers in Spain and Japan have found that in 32 out of 33 experimental trials, people walking freely
Climate
Health
Environmental factors affecting dog health and wellbeing
Alvina Miller June 11, 2026: A dog’s health depends on more than genetics, food, and veterinary care. The air it breathes, the heat
Drugs
Gilead and Merck’s once-weekly HIV pill passes two major trials
HQ Team June 10, 2026: Pharmaceutical giants Gilead Sciences and Merck announced that a once-weekly, single-tablet HIV treatment made up of islatravir and
Drugs
Health
GLP-1 drugs cut blood clot and death risk in obese, autoimmune disease patients
HQ Team June 10, 2026: A major real-world study of more than 26,000 adults in the United States has found that popular GLP-1
Drugs
Pharma
AI-designed universal vaccine against coronavirus passes human trial
HQ Team June 9, 2026: Researchers at the University of Cambridge and UK biotech firm DIOSynVax have designed a vaccine targeting the entire